Tag Archives: Dr Ajay Aggarwal

New study led by Dr Courtney Davis published in the BMJ today shows that most new cancer drugs entering the European market are failing to deliver any clinically meaningful benefit

Almost two thirds (57%) of cancer drugs authorised by the European Medicines Agency (EMA) between 2003 and 2009 came onto the market without any clear evidence they improved the quality or quantity of patients’ lives, according to research from King’s … Continue reading

Posted in Medicine Health and Public Policy | Tagged , , | Leave a comment